Actueel

Governance & Proxy
Mrt 4 2014 | 6:06 PM | Gepost Door:

Each year, investors file shareholder proposals with public companies to requesting that their proposals be included for a vote at the next annual meeting of shareholders. 

Lees Meer
Asia Pacific Markets
Jan 29 2014 | 5:24 PM | Gepost Door:

Even as an improving US economy sparked renewed interest in US stocks last year, trading in international equities listed on NYSE markets remained solid, approaching $3.1 trillion.

Lees Meer
Meest Recent
April 23, 2014
NYSE MAC Desk
Apr 23 2014 | 10:12 AM

From The Trading Floor: Equities are retreating a bit this morning after 6 straight days of advancement on a mixed bag of earnings and weaker economic data



  • Mortgage Applications fell by -3.3% for the week ending April 18th

  • The Markit Economics preliminary US. Manufacturing Index decreased to 55.4 in April from a final reading of 55.5 a month earlier

  • Sales of new US. Homes unexpectedly plunged in March by -14.5% to 384,000, its lowest level in 8 months

  • Procter & Gamble reports Q3 EPS $1.04, consensus $1.02. Reports Q3 revenue $20.56B, consensus $20.68B.

  • Yum! Brands reports Q1 EPS ex-items 87c, consensus 85c. Reports Q1 revenue $2.72B, consensus $2.8B

  • China's manufacturing sector has contracted for a fourth consecutive month in April, although the HSBC PMI gauge has edged up to 48.3 from 48 in March. "Domestic demand showed mild improvement and deflationary pressures eased...
Lees Meer
Gepost Door: Charles Brown
Managing Director, The Capital Markets Desk
Ahead of the Bell
Apr 23 2014 | 8:30 AM

Ahead of the Bell: Dow futures are trading down 4 points and S&P futures are trading down 2 points. Euro zone private businesses rose to their best month in April in nearly three years, but stuttering Chinese factory activity over shadowed the positive sentiment after it shrank for a fourth straight month in April, according to surveys. Growth in the 17-member bloc was sphere-headed by Germany where its PMI jumped from March after the region's services industry led the charge while manufacturers also had a stronger month. Market participants are hopeful that China has turned the corner after the government introduced policy steps to combat the slowdown in the world's second biggest economy. The crisis in Ukraine continues to drag on financial markets after the US threatened Russia with more sanctions and Ukraine's government said it was restarting an "anti-terrorist operation" to eliminate armed pro-Russian separatist groups.

...
Lees Meer
Gepost Door: Parasnand Madho
Director, Market Watch & Corporate Actions
End of Day Report
Apr 22 2014 | 4:33 PM

Benchmark US stock indices extended recent gains on Tuesday amid a busy round of earnings, an increase in M&A activity and slightly better-than-expected existing home sales.  Healthcare and Discretionary led gains on the S&P 500, while Energy and Staples were the only major sectors to finish in the red.  Crude oil is sharply lower while gold and the dollar are only slightly lower.    


 


Better-than-expected earnings have lifted equities recently, with today marking a sixth straight day of advances, though companies have largely been exceeding reduced forecasts.  Profits are seen rising 1.1% this quarter, down from the 6.5% growth rate estimated at the start of the year.  Pharma also M&A grabbed much of the days’ headlines, pushing the Healthcare sector higher.  Yesterday was about speculation, today we saw actual announcements. 


 


In U.S. economic news...

Lees Meer
Specialist, Market Watch
NYSE MAC Desk
Apr 22 2014 | 10:19 AM

From The Trading Floor: Earnings in combination with M&A activity in the Pharma sector have given the markets a spark this morning.



  • FHFA House Price Index for February came in at 0.6% slightly ahead of the 0.5% estimate

  • The Richmond Fed Manufacturing Index came in at 7 vs the 2 consensus

  • US. March Existing Home Sales fall 0.2% to 4.59 million rate exceeding the 4.56 million estimate

  • Valeant and Bill Ackman's Pershing Square are teaming up to make a bid for Allergan (AGN) that could be worth over $45B.

  • Novartis has agreed to acquire GlaxoSmithKline's (GSK) oncology products for an initial $14.5B and up to $1.5B in development milestones. In return, GSK will buy the Swiss company's vaccines business for $5.25B upfront and as much as $1.8B in milestones, as well as royalties.

  • Novartis has also agreed to sell its animal-health division to Eli Lilly (LLY) for around $5.4B....
Lees Meer
Gepost Door: Charles Brown
Managing Director, The Capital Markets Desk
Ahead of the Bell
Apr 22 2014 | 8:07 AM

Ahead of the Bell: Dow futures are trading up 5 points and S&P futures are trading up 2 points. Global shares are buoyed by M&A activity, speculation of QE by the ECB, and China's central bank action. Merger activity in the pharmaceutical sector involving Eli Lilly, GlaxoSmithKline, and Novartis and Valiant Pharmaceuticals International Inc., and Allergan Inc., are lifting futures trading after markets in Germany, England, Hong Kong, and Australia reopened following the Easter holidays. There is rising expectations among investors of further policy easing by the European Central Bank after the region reported inflation is running at 0.5%. China's yuan fell to its lowest level in 14 months against the dollar, after the central bank set a lower official midpoint of its trading range, highlighting its desire for a weaker currency to manage an economic slowdown.


 



  • On the...
Lees Meer
Gepost Door: Parasnand Madho
Director, Market Watch & Corporate Actions